Search results
Results from the WOW.Com Content Network
As of 2018, J&J committed to working with the Indian government to support all Indian ASR patients. In late 2018, an Indian government report, the accuracy of which has been disputed by J&J, proposed that each patient who had a faulty implant should receive a lump sum payment of ₹2 million ( US$27,812 ).
At 120,000 square feet (11,000 m 2), this facility occupies a fraction of the J&J campus, which encompasses 69 acres (280,000 m 2) in total. Manufacturing at JJM began in February 2008. On August 24, 2010, DePuy recalled [4] all ASR hip implant systems sold since 2003.
6.3 2010 hip-replacement recall. 6.4 2010 Tylenol ... (J&J) is an American ... In September of the same year Johnson & Johnson Medical GmbH acquired Emerging Implant ...
Its DePuy division's recall of faulty hip-replacement devices has touched off thousands of patient lawsuits; J&J has set aside at least $922 million to cover litigation costs. ... Last year's ...
It's been nearly a month since Johnson & Johnson (JNJ) issued the largest recall of children's medicine in the history of the U.S. Food and Drug Administration, and the fallout may be just ...
The Committee on Oversight and Government Reform today held its hearing on Johnson & Johnson's (JNJ) recall of children's medicine -- the largest in the history of the U.S. Food and Drug ...
The analysis of 402,051 hip replacements showed that 6.2% of metal-on-metal hip implants had failed within five years, compared to 1.7% of metal-on-plastic and 2.3% of ceramic-on-ceramic hip implants. Each 1 mm (0.039 in) increase in head size of metal-on-metal hip implants was associated with a 2% increase in failure rate. [63]
J&J CEO Weldon Apologizes for Recalls. Johnson & Johnson CEO William Weldon (pictured) apologized to Congress Thursday for a series of issues that recently have beset the world's biggest health ...